Short answer is yes, potentially. It depends on a
Post# of 148160
(Total Views: 494)
Posted On: 03/27/2020 8:50:06 AM
Short answer is yes, potentially. It depends on a lot of things.
The main issue being that if out manufacturers have contractual agreements with other clients to produce other medications, and those processes are up and running, there is not much that can be done at the moment. I know this is a global issue, but potentially shorting supply of other medication is also an issue.
The way manufacturing campaigns are scheduled is to have multiple productions runs staggered. This allows for several run to complete within a few days or weeks of one another. So depending on the size of the campaign there could be quite a bit of product delivered within a 2 month period from the initial start date.
The good news is that a company like Samsung with its massive capacity and capability, may be able to make adjustments. And yes, funds ASAP as this would be costly.
The main issue being that if out manufacturers have contractual agreements with other clients to produce other medications, and those processes are up and running, there is not much that can be done at the moment. I know this is a global issue, but potentially shorting supply of other medication is also an issue.
The way manufacturing campaigns are scheduled is to have multiple productions runs staggered. This allows for several run to complete within a few days or weeks of one another. So depending on the size of the campaign there could be quite a bit of product delivered within a 2 month period from the initial start date.
The good news is that a company like Samsung with its massive capacity and capability, may be able to make adjustments. And yes, funds ASAP as this would be costly.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼